ACIP Reports on First “Do-It-Yourself at Home” Nasal Flu Shot

In September 2024, the U.S. Food and Drug Administration (FDA) licensed the first of its kind live attenuated nasal spray influenza vaccine to be administered at home during the 2024-2025 “flu season.” Adults up to the 49 years of age are eligible to self-administer the FluMist Home vaccine or give it to their children aged […]
Moderna Faces Suspension in U.K. Over Allegations of Bribing Children to Join mRNA COVID-19 Shot Trials

U.S. vaccine manufacturer Moderna is under investigation in the United Kingdom over claims it offered children financial incentives to participate in clinical trials of the mRNA COVID-19 biological, which is an alleged breach of British pharmaceutical regulations that could result in the company’s suspension from the country’s industry trade body.1 According to reports, children were […]
Autism Epidemic ‘Unprecedented in Human History,’ Now Reaches 1 in 31 Kids in America

On Apr. 15, 2025, the U.S. Centers for Disease Control and Prevention (CDC) published an analysis in its epidemiological digest Morbidity and Mortality Weekly Report (MMWR) which found the prevalence of autism spectrum disorder (ASD) among children eight years old in the United States to be 1 in 31 (3.2 percent).1 2 3 4 5 […]
The Truth About Whooping Cough in the U.S.

Once again, this year, Americans are being warned that B pertussis whooping cough cases are on the rise and society is being endangered by parents who don’t vaccinate their children. That myth goes back to the early 1980s when parents of DPT-injured children in the U.S. were calling for a less reactive pertussis vaccine, because […]
Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated

The American Medical Association (AMA) cites that the influenza vaccine is estimated to be 40-60 percent effective at preventing serious infections or death from the influenza virus that affects up to 40 million Americans every year. However, for the 2024-2025 flu “season” the influenza vaccine not only missed the mark on effectiveness, but is linked […]
CDC’s ACIP Forms Workgroup to Back New Lyme Disease Vaccine and Monoclonal Antibody Products

At an Apr.15-16, 2025 meeting of the U.S. Centers for Disease and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), it was announced that a workgroup had been formed to further development of a new vaccine for Lyme disease. The first session of the new group will take place in May with a presentation scheduled […]